Konski has done a lot of patent work recently for clients involved in "companion diagnostics."
For instance, she's advising researchers at the University of Southern California who are developing diagnostic tests to analyze an individual's genetic makeup to determine if a specific cancer drug will help the patient.
The U.S. Food and Drug Administration recently released regulatory guidance for companion diagnostics. <...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In